Phase I/Ii study of mTOR inhibitor everolimus and Hyper-CVAD plus RAD001 (Everolimus) chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60540
下载链接
链接失效反馈官方服务：
资源简介：
Analysis of the effects of everolimus on gene expression and if this correlates to drug and/or clinical response. RNA exracted from peripheral blood before and 24 hours after treatment with everolimus.
创建时间：
2018-08-13
